logo

For the Inventor, By the Inventor

Milan, Italy

Alberto Cerri

This inventor holds 20 USPTO granted patents and 8 EPO patents, primarily in Cardiovascular Therapeutics. Top assignees: Sigma-Tau Industrie Farmaceutiche Riunite S.p.a., Cvie Therapeutics Limited, Rostaquo S.p.a.. Active years: 1994-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alberto Cerri. Retrieved from https://idiyas.com/inventor/alberto-cerri

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 20

% Patents Active = 55.0

 

Average Co-Inventor Count = 5.2

ph-index = 3

Forward Citations = 24(Granted Patents)


Location History:

  • Gessate MI, IT (1994 - 1995)
  • Gessate, IT (1996 - 2007)
  • Milan, IT (2011 - 2023)

Company Filing History:

goldMedal17 out of 343 
 
Sigma-Tau Industrie Farmaceutiche Riunite S.p.a.
 patents
silverMedal1 out of 1 
 
Cvie Therapeutics Limited
 patent
bronzeMedal1 out of 2 
 
Rostaquo S.p.a.
 patents
4. 1 out of 1 
 
Seismic Pharmaceuticals
 patent

Years Active: 1994-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Androstane Derivatives
SERCA2a Stimulants
Cardiovascular Disorders
Heart Failure
Crystalline Rostafuroxin
Diterpenoid Derivatives
Amino Derivatives
Beta-Homoandrostanes
Hypertension Treatments
Medicaments
Azaheterocyclyl Compounds
Hydrazino Derivatives
20 patents (USPTO):Explore Patents
1. 12503484 - Androstane derivatives with activity as pure or predominantly pure stimulators of SERCA2a for the treatment of heart failure (2025-12-23),
2. 11730746 - 17beta-heterocyclyl-digitalis like compounds for the treatment of heart failure (2023-08-22),
3. 9127037 - Crystalline rostafuroxin (2015-09-08),
4. 8822692 - Diterpenoid derivatives endowed of biological properties (2014-09-02),
5. 8664210 - Aminooxime derivatives of 2- and/or 4-substituted androstanes and androstenes as medicaments for cardiovascular disorders (2014-03-04),
6. 8609644 - Amino derivatives of androstanes and androstenes as medicaments for cardiovascular disorders (2013-12-17),
7. 8536160 - Azaheterocyclyl derivatives of androstanes and androstenes as medicaments for cardiovascular disorders (2013-09-17),
8. 8022203 - Amino derivatives of beta-homoandrostanes and beta-heteroandrostanes (2011-09-20),
9. 7247747 - Process for preparing R-(-)carnitine from S-(-)-chlorosuccinic acid or from a derivative thereof (2007-07-24),
10. 6984739 - Process for preparing R-(−)-carnitin from S-(−)-chlorosuccinic acid or from a derivative thereof (2006-01-10),
11. 6677476 - Process for preparing R-(-) -carnitine from S-(-)-chlorosuccinic acid or from a derivative thereof (2004-01-13),
12. 5792759 - 17-hydroxyiminoalkyl and 17-hydroxyiminomethylalkenyl (1998-08-11),
13. 5705662 - 17-(3-imino-2-alkylpropenyl)-5.beta., 14.beta.-androstane derivatives (1998-01-06),
14. 5705531 - 1,5-disubstituted 7A-methylperhydroinden-3A-ol derivatives, useful in (1998-01-06),
15. 5599806 - Hydrazino and hydroxyamino-14-.beta.-hydroxyandrostane derivatives (1997-02-04),

Title: Alberto Cerri - Innovative Inventor from Milan

Introduction: Alberto Cerri is a renowned inventor hailing from Milan, Italy, known for his groundbreaking contributions to various fields of technology and innovation.

Latest Patents: Alberto Cerri holds several patents in the areas of renewable energy, sustainable materials, and advanced robotics, showcasing his commitment to creating a more sustainable future.

Career Highlights: With a career spanning over two decades, Alberto Cerri has worked with leading research institutions and universities to develop cutting-edge technologies that have revolutionized industries worldwide.

Collaborations: Throughout his career, Alberto Cerri has collaborated with top companies, innovative startups, and talented individuals to bring his inventions to life and make a lasting impact on society.

Conclusion: Alberto Cerri's passion for innovation and his dedication to pushing the boundaries of what is possible have solidified his reputation as a visionary inventor in the global tech community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…